Clinical beta
FMBM is currently in clinical beta. Content is for professional review/testing and must not replace local protocols, senior clinical judgment, or official prescribing references.
Drug Monograph
USE IF: Seizure disorders, bipolar disorder, selected neurologic/psychiatric indications
AVOID IF: Pregnancy (unless no safer alternative), significant liver disease, or high hepatotoxicity risk
Valproate (Valproic Acid / Sodium Valproate)
Broad-spectrum antiepileptic and mood stabilizer
Indication
Seizures • Bipolar disorder • Mood stabilization
INDICATIONS (CORE USE)
- Seizure disorders (broad-spectrum) - Bipolar disorder (mood stabilization)
ADULT DOSE (STANDARD)
Start low and titrate based on response and levels Loading may be used in acute settings (protocol-based)
MAX DOSE
Protocol- and level-guided; avoid rapid escalation and dose beyond monitoring capacity
Route
PO • IV
PEDIATRIC DOSE
Protocol-based
Must-not-miss safety points
Major warning
- Hepatotoxicity can be severe or fatal - Pregnancy exposure carries major teratogenic risk - Hyperammonemia may present with confusion or encephalopathy - Thrombocytopenia and pancreatitis are important toxicity signals
Institutional protocol required
Dosing for this medication is not a substitute for your hospital order set, pharmacy verification, or specialty protocol. Use only with an approved institutional pathway, continuous monitoring, and independent double-check where policy requires.
FMBM beta: decision support only — not medical advice or a prescribing system.
INDICATION: Seizures • Bipolar disorder • Mood stabilization
Primary
Secondary
Institutional protocol required
Dosing for this medication is not a substitute for your hospital order set, pharmacy verification, or specialty protocol. Use only with an approved institutional pathway, continuous monitoring, and independent double-check where policy requires.
Numeric examples in this monograph are illustrative only when present — always follow your verified institutional protocol and product labeling.
FMBM beta: decision support only — not medical advice or a prescribing system.
STANDARD (ADULT PO)
Start low and titrate gradually; adjust based on clinical response and serum levels
ADULT DOSE
STANDARD (ADULT): - Start low and titrate gradually - Adjust based on clinical response and serum levels
PEDIATRIC DOSE
Protocol-based
MAX DOSE
Protocol- and concentration-guided dosing; avoid rapid escalation
Practical Note
- Monitor levels in selected patients - Avoid rapid dose escalation - IV and PO can be interchanged in acute settings per protocol
Clinical warnings
Adverse effects
Pediatrics
Protocol-based
Pregnancy
Pregnancy: Avoid when possible due to high teratogenic risk; use only when no safer effective alternative exists
Lactation
Follow specialist guidance and monitor infant if exposure is expected.
Renal impairment
Renal disease may alter free (active) fraction despite total level interpretation; monitor clinically and by levels when indicated.
Hepatic impairment
High hepatic risk; avoid or use extreme caution with close laboratory surveillance.
Elderly
Monitor sedation, cognition, and serum levels more closely.
- PO or IV - Titrate slowly - Monitor clinically and with labs
Clinical Picture
CNS depression, hyperammonemia, and metabolic disturbances
Immediate Actions
Supportive care, evaluate ammonia and metabolic status, and escalate to ICU-level support if severe
Antidote
L-carnitine in severe toxicity per protocol
Decontamination
Per toxicology protocol and timing of ingestion
Escalation
Escalate urgently for progressive CNS depression, organ dysfunction, or severe metabolic derangement
Common mistakes, resistance logic, and bedside traps
Pharmacy Tool
solution · oral
Pharmacist verification beta
Preparation formulas are currently in pharmacist verification beta and must be validated against institutional protocols before use. Additional safeguards apply (high-alert medication).
Acknowledge the statements above to unlock volume scaling and ingredient quantities.
- Hepatic metabolism - Protein-bound - Level monitoring is useful in selected scenarios
- Increases GABA activity and stabilizes neuronal firing
Saudi Arabia
Depakine, Epilim, Convulex
Global
Depakote, Valproate, Valproic acid, Sodium valproate, (placeholder — verify local formulation)
Common trade names are curated examples only — formulations and availability vary. Verify the exact product name with your local pharmacy and national regulator before prescribing or dispensing.
Global data (no country-specific data available)
Saudi Arabia
International